Summary
Definition
History and exam
Key diagnostic factors
- low hand grip strength
- difficulty rising from chair
- difficulty climbing stairs
- slow gait
- emaciation
- difficulty performing activities of daily living
Other diagnostic factors
- presence of comorbidities affecting muscle mass and/or function
Risk factors
- age ≥65 years
- low or high body mass index (BMI)
- sedentary lifestyle
- low protein intake
- falls
- smoking
Diagnostic tests
1st tests to order
- serum electrolytes
- blood glucose
- LFTs
- renal function tests
- thyroid function tests
- CBC
- serum vitamin D
- dual-energy x-ray absorptiometry (DXA)
- CT
- MRI
Tests to consider
- bioimpedance analysis (BIA)
Treatment algorithm
all patients
Contributors
Authors
Gustavo Duque, MD, PhD
Professor
Faculty of Medicine
McGill University
Quebec
Canada
Disclosures
GD serves as a member of the Advisory Boards of Abbott Australia and TSI Pharmaceuticals. He also belongs to the speakers' bureau for Amgen and Abbott Australia. These companies produce therapeutic compounds that have demonstrated an effect on sarcopenia
Guy Hajj-Boutros, PhD(c)
PhD candidate
Division of Experimental Medicine
McGill University
Quebec
Canada
Declarações
GHB declares that he has no competing interests.
José A. Morais, MD
Professor
Faculty of Medicine
McGill University
Quebec
Canada
Declarações
JAM has received fees from Sanofi for clinical expertise on Fluzone vaccine. He is a member of the Board of the Fonds de Recherche du Québec. He has performed contracted research for the Canadian Space Agency. JAM has also received operating grants from the Canadian Institutes of Health Research.
Revisores
Stephanie Anne Studenski, MD, MPH
Professor Emeritus
Department of Medicine
University of Pittsburgh
Pittsburgh
PA
Declarações
SAS declares that she has no competing interests.
Miles Witham, PhD
Professor of Trials for Older People and consultant geriatrician
NIHR Newcastle Biomedical Research Centre
Newcastle University
Newcastle
UK
Declarações
MW declares that he has no competing interests.
Referências
Principais artigos
Cruz-Jentoft AJ, Bahat G, Bauer J, et al; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31.Texto completo Resumo
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22(10):1148-61. Resumo
Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020 Jul;68(7):1410-8. Resumo
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-7. Resumo
Izquierdo M, Merchant RA, Morley JE, et al. International exercise recommendations in older adults (ICFSR): expert consensus guidelines. J Nutr Health Aging. 2021;25(7):824-53.Texto completo Resumo
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Parkinson disease
- Amyotrophic lateral sclerosis
- Myopathy
Mais Diagnósticos diferenciaisDiretrizes
- Sarcopenia: revised European consensus on definition and diagnosis
- International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal